rethinkPeptides Search
Menu
Study breakdown

Gastric Bypass Patients Burn More Calories After Meals 9 Years Later — Driven by Elevated GLP-1 and PYY Gut Peptides

evidence
The takeaway

Nine years after surgery, gastric bypass patients burned more calories after eating and had dramatically higher GLP-1 and PYY gut peptide levels than patients who had restrictive surgery.

GLP-1 & PYY: both p<0.001

gut peptide hormones were significantly higher after gastric bypass vs restrictive surgery 9 years post-operatively, linked to greater calorie burning

What the researchers found

Nine years after surgery, gastric bypass patients had significantly higher postprandial energy expenditure (p=0.018) and total 24-hour energy expenditure (p=0.048) compared to vertical banded gastroplasty (VBG) patients, despite similar body composition and food intake. Gastric bypass also produced significantly higher postprandial levels of the gut peptide hormones PYY and GLP-1 (both p<0.001). These exaggerated peptide responses may drive the increased calorie burning that explains superior long-term weight loss maintenance.

Why it matters

Understanding why gastric bypass produces better long-term weight loss than restrictive surgery like VBG is key to developing non-surgical obesity treatments. This study shows the advantage persists for at least 9 years and is linked to elevated gut peptide hormone responses — the same peptides (GLP-1, PYY) targeted by modern weight-loss drugs like semaglutide.

The numbers in context

n=14 · 9 years post-surgery · higher postprandial EE (p=0.018) · higher 24h EE (p=0.048) · PYY and GLP-1 both p<0.001 · similar body composition and food intake

How the study worked

Fourteen women from a randomized clinical trial (7 gastric bypass, 7 VBG) were assessed 9 years postoperatively at weight stability. Energy expenditure was measured via 24-hour indirect calorimetry in a respiratory chamber, with focus on postprandial and sleep periods. Body composition and calorie intake were assessed. Postprandial blood samples measured PYY and GLP-1 gut peptide hormone responses.

Who was studied

14 women assessed 9 years after randomization to either gastric bypass or vertical banded gastroplasty

What this study cannot tell us

Very small sample size (n=14, 7 per group). Only female participants. Single time-point assessment at 9 years — no longitudinal tracking of when the peptide differences emerged. Cannot establish causality between elevated GLP-1/PYY and increased energy expenditure. The groups were from a randomized trial, which is a strength, but the small numbers limit statistical power.

How to read the evidence

This is a long-term follow-up (9 years) from a randomized clinical trial, which is a strong design. However, the very small sample size (n=14) and all-female cohort limit generalizability. The peptide-energy expenditure link is associative, not proven causal.

When this study was published

Published in 2013, this study was ahead of its time in linking gut peptide hormones to energy expenditure differences between surgical techniques. These findings have since been supported by the success of GLP-1 receptor agonist drugs for weight management.

The bigger picture

This study provides mechanistic evidence for what makes gastric bypass uniquely effective: it permanently amplifies gut peptide hormone signaling (GLP-1, PYY) in a way that increases calorie burning, not just appetite reduction. This insight has directly informed the development of GLP-1 receptor agonist drugs like semaglutide and tirzepatide, which aim to pharmacologically mimic some of the hormonal changes produced by surgery — making obesity treatment possible without an operation.

Questions still open

  • Can combination GLP-1/PYY peptide drug therapy replicate the enhanced energy expenditure seen after gastric bypass?
  • Do the elevated gut peptide levels remain elevated beyond 9 years, or do they eventually decline?
  • Would male patients show the same energy expenditure and peptide differences between surgical techniques?

Common questions

What are GLP-1 and PYY and why do they matter for weight?
GLP-1 (glucagon-like peptide-1) and PYY (peptide YY) are natural gut hormones released after eating that signal fullness to the brain and, as this study shows, increase calorie burning after meals. They're the biological basis for weight loss drugs like semaglutide (Ozempic/Wegovy). Gastric bypass surgery dramatically amplifies their release — an effect lasting at least 9 years.
Why does gastric bypass increase these peptide hormones but restrictive surgery doesn't?
Gastric bypass reroutes food to bypass the upper small intestine, causing partially digested nutrients to reach the lower gut more quickly. The lower gut is where GLP-1 and PYY are produced, so this anatomical change creates exaggerated peptide release after every meal. Restrictive surgery like VBG simply makes the stomach smaller without changing gut anatomy, so peptide responses remain normal.

Read the original research

Increased postprandial energy expenditure may explain superior long term weight loss after Roux-en-Y gastric bypass compared to vertical banded gastroplasty.

PloS one, 8(4), e60280

Citation

Werling, Malin; Olbers, Torsten; Fändriks, Lars; Bueter, Marco; Lönroth, Hans; Stenlöf, Kaj; le Roux, Carel W. (2013). Increased postprandial energy expenditure may explain superior long term weight loss after Roux-en-Y gastric bypass compared to vertical banded gastroplasty.. PloS one, 8(4), e60280. https://doi.org/10.1371/journal.pone.0060280